Today’s top gainers include the company Quest Diagnostics Inc. (NYSE:DGX) which is in the industry Medical Laboratories & Research, gaining -0.21% today. In the last week its performance is 2.97%, and 12.72% for the past quarter. Currently, Quest Diagnostics Inc., DGX has a target price of 75.8, so today’s gain of -0.21% is a significant step towards its target price. The GAP today is therefore -0.64%.
Quest Diagnostics Inc. (NYSE:DGX), has a market cap of 11515.77, and is based in USA. Insider ownership is at 0.40%, and institutional ownership is 96.60%.
At the current price of 81.24, it has a dividend yield of 1.97%, and its target price is 75.8. This is with a profit margin of 9.90%, and total debt/equity of 0.84. Quest Diagnostics Inc. (NYSE:DGX) has a P/E of 15.74, as well as a forward P/E of 14.99.
With a current EPS of 5.16, and a forecasted EPS growth for next year at 6.42%,Quest Diagnostics Inc. (NYSE:DGX) has had a EPS growth for the past five years at 4.10%. For the next five years EPS growth is projected to be 7.72%.
Performance for the year is 15.69%. Since its IPO date on 12/26/1996, the total performance to date is 15.47%.
Volume today for Quest Diagnostics Inc. (NYSE:DGX), is 1147682, while its average volume is 1122.78. Whilst the total gain today was -0.21%, it did have a day high of -0.21%.
Volatility for this week has been at 1.63%, and 1.70% for the month. The 52-week low for Quest Diagnostics Inc., DGX has been 37.60%, while the 52-week-high has reached -0.21%.
Looking at its return of investments, which is 12.30%, and its return on assets is 7.50%. Quest Diagnostics Inc. (NYSE:DGX) has an operating margin of 19.00%. With a sales growth of 1.30% quarter over quarter. Bearing in mind that Quest Diagnostics Inc., DGX is in the sector Healthcare, its long-term debt/equity is 0.81, and has a current ratio of 1.4 and 1.3 for quick ratio.
So what is the value of Quest Diagnostics Inc.? Well its PEG is 2.04, and the P/S is 1.53, along with a P/B of 2.51. Meanwhile it has a p/cash of 89.97.